Publikationen in Zusammenarbeit mit Forschern von Hospital de Fuenlabrada (7)

2023

  1. HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment

    Cancers, Vol. 15, Núm. 3

2022

  1. FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19

    Medicina Clinica, Vol. 156, Núm. 2, pp. 55-60

  2. Genetic variants of ANGPT1, CD39, FGF2 and MMP9 linked to clinical outcome of bevacizumab plus chemotherapy for metastatic colorectal cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-16

  3. Mir-7, mir-10a and mir-143 expression may predict response to bevacizumab plus chemotherapy in patients with metastatic colorectal cancer

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1263-1273

  4. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2020

  1. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports

    World journal of gastroenterology, Vol. 26, Núm. 16, pp. 1979-1986